Sagicor: Core Earnings Rebound, but Volatility and US Legacy Mortality Remain the Story

Q2 2026 shows improved core results and reaffirmed 2027-28 ROE targets, but management is wrestling with persistent insurance experience volatility and a deep dive into the US legacy block.

SFC.TO · Earnings Call · 2026-08-13

Back to Target Levels

Sagicor Financial Company (SFC.TO) reported Q2 2026 core earnings of $34M, up from $25M in Q1, and net income of $87M, driven by favorable market movements. Management described the quarter as “Another solid quarter” — Andre Mousseau, Unknown (likely senior executive, possibly CEO or CFO) · 2026-08-13 with core earnings returning to target levels and insurance experience broadly in line with expectations. The core earnings recovery was led by improvements in insurance experience and investment portfolio performance, while net income benefited from lower interest rates in Canada and strong equity markets. Annualized core ROE hit 13.6%, close to the 14% target for 2027.

Strategic Initiatives and the Caribbean Transformation

The company continues to execute on its strategic pillars. A notable highlight is the A.M. Best credit rating upgrade to A for the US business, which management believes “will help open up further distribution opportunities” — Andre Mousseau, Unknown (likely senior executive, possibly CEO or CFO) · 2026-08-13 as it accelerates US growth. In the Caribbean, the pending combination of Sagicor Life and Sagicor Jamaica is progressing. Management expects closing in Q4 or early next year, and highlighted that “we do expect we'll start to see more onetime charges and investments in the third and fourth quarters” — Andre Mousseau, Unknown (likely senior executive, possibly CEO or CFO) · 2026-08-13 as the transformation accelerates. The company's value creation targets remain intact: a path to 14% ROE in 2027 and 15% in 2028.

Volatility: A Deliberate Trade-Off

A key discussion point was the company's elevated earnings volatility relative to Canadian peers. Analyst Darko Mihelic asked whether management has considered hedging or shortening the asset base to reduce tails. CEO Andre Mousseau acknowledged the issue and explained the philosophy:

We are playing with a North Star here of generating strong long-term return on equity... we've made the strategic decision for the time being that we're going to optimize the economics for how much book value generation can we get over the next 2, 3, 4 years and beyond rather than shortening up and feeling it a little bit more comfortable.
Andre Mousseau, Unknown (likely senior executive, possibly CEO or CFO) · 2026-08-13

This stance underscores the company's acceptance of lot of volatility as a trade-off for higher long-term returns. Mousseau also noted that reported results over 14 quarters have tracked core earnings well, but the quarterly swings are more pronounced because of the proportion of traditional balance-sheet life insurance in the mix compared to capital-light businesses of larger peers.

US Legacy Block and Reserve Strengthening

Another recurring theme is the negative mortality experience in the US legacy life block. Management indicated this has persisted for several quarters and is considering a reserve strengthening. Mousseau said they are taking a deep dive into mortality assumptions for Q3, and "if we knew what the answer was, we'd have put it out in Q2." The annuities business written in the last five years is performing in line with expectations, but the old block requires careful cohort-by-cohort analysis. This could lead to CSM reductions or equity charges, adding to near-term noise.

Outlook and Balance Sheet Actions

Despite the volatility, the company remains well capitalized with a group LICAT ratio of 134% and a financial leverage ratio of 27.4%. Book value per share increased to USD 7.65 (CAD 10.87). Management repurchased 0.5 million shares for ~$3M during the quarter and announced the 27th consecutive quarterly dividend, raising it to $0.075 per quarter. These actions signal confidence in the underlying business as it navigates the transformation. In summary, Sagicor delivered a solid quarter with core earnings back on track, but the persistent volatility and the unresolved US legacy mortality issue keep the stock's risk profile elevated. The company's willingness to accept near-term swings for long-term book value generation is a deliberate strategy, but the market will watch for the promised reserve actions and the closure of the Caribbean deal as key catalysts into 2027.